Development of metastatic disease after enrollment in the COMS trials for treatment of choroidal melanoma: Collaborative Ocular Melanoma Study Group Report No. 26.

M, Diener-West; SM, Reynolds; DJ, Agugliaro; R, Caldwell; K, Cumming; JD, Earle; BS, Hawkins; JA, Hayman; I, Jaiyesimi; LM, Jampol; JM, Kirkwood; WJ, Koh; DM, Robertson; JM, Shaw; BR, Straatsma; J, Thoma

doi:10.1001/archopht.123.12.1639

Public

Development of metastatic disease after enrollment in the COMS trials for treatment of choroidal melanoma: Collaborative Ocular Melanoma Study Group Report No. 26.

Shared by NobleBlocks on Dec 1, 2005 • 12:00 AM UTC

Authors:

Diener-West M

Reynolds SM

Agugliaro DJ

Abstract

<h4>Objective</h4>To describe the time between treatment for choroidal melanoma and first diagnosis of metastatic disease, sites of metastasis, treatments for metastasis, and time between diagnosis of metastasis and death.<h4>Design</h4>Prospective, longitudinal follow-up of patients diagnosed with ...

Discussions